Skip to main content

Clinical Trial Results

Primary Navigation

Home
Slide Library
This Week in Medicine®
Past Videos
About
Contact

Dr. Richard Cheng and Dr. C. Michael Gibson discuss: Presentation, screening, and disease progression of variant ATTR-CM

Search for:
Search archived content (2018 and prior)

June 4, 2025

Disclosures: Sponsored by BridgeBio Pharma, Inc

Article Navigation

Dr. Kevin Alexander and Dr. C. Michael Gibson discuss datapresented at ACC 2025: Dr. Kevin Alexander, Acoramidis Improves Serum TTR Levels in Patients with Wild-Type or Variant Transthyretin Amyloid Cardiomyopathy sponsored byBridgeBio Pharma, Inc.

Footer Navigation

LinkedIn
Twitter
Email

Search for:
Search archived content (2018 and prior)